Adrenergic and muscarinic receptor regulation and therapeutic implications in heart failure (Q41062697)

26 September 2017

1 reference

title

Adrenergic and muscarinic receptor regulation and therapeutic implications in heart failure (English)

1 reference

26 September 2017

0 references

W Schmitz

1

1 reference

26 September 2017

P Boknik

series ordinal

2

1 reference

26 September 2017

B Linck

series ordinal

3

1 reference

26 September 2017

F U Müller

series ordinal

4

1 reference

26 September 2017

1 April 1996

1 reference

Molecular and Cellular Biochemistry

26 September 2017

1 reference

26 September 2017

157

1 reference

26 September 2017

1-2

1 reference

26 September 2017

251-258

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00227907

26 September 2017

0 references

cites work

Two Ca2+ ATPase genes: homologies and mechanistic implications of deduced amino acid sequences

1 reference

12 December 2020

Radioimmunochemical quantification of Gi alpha in right and left ventricles from patients with ischaemic and dilated cardiomyopathy and predominant left ventricular failure

1 reference

12 December 2020

Basal and isoprenaline-stimulated cAMP content in failing versus nonfailing human cardiac preparations

1 reference

12 December 2020

cAMP concentrations, cAMP dependent protein kinase activity, and phospholamban in non-failing and failing myocardium

1 reference

12 December 2020

Increase in myocardial Gi-proteins in heart failure

1 reference

12 December 2020

Calcium uptake by cardiac sarcoplasmic reticulum in human dilated cardiomyopathy

1 reference

12 December 2020

Ca(2+)-transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing human myocardium

1 reference

12 December 2020

Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure

1 reference

12 December 2020

Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium

1 reference

12 December 2020

Increased expression of cardiac phosphatases in patients with end-stage heart failure

1 reference

12 December 2020

Effect of propranolol after acute myocardial infarction in patients with congestive heart failure

1 reference

12 December 2020

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

12 December 2020

Phospholamban-mediated stimulation of Ca2+ uptake in sarcoplasmic reticulum from normal and failing hearts

1 reference

12 December 2020

Nitric oxide regulates cardiac Ca2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation.

1 reference

12 December 2020

Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators

1 reference

12 December 2020

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

12 December 2020

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group

1 reference

12 December 2020

Amino-acid sequence of a Ca2+ + Mg2+-dependent ATPase from rabbit muscle sarcoplasmic reticulum, deduced from its complementary DNA sequence.

1 reference

12 December 2020

Effects of Isomazole on Force of Contraction and Phosphodiesterase Isoenzymes I-IV in Nonfailing and Failing Human Hearts

1 reference

12 December 2020

Altered sarcoplasmic reticulum Ca2(+)-ATPase gene expression in the human ventricle during end-stage heart failure

1 reference

12 December 2020

Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group

1 reference

12 December 2020

Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium

1 reference

12 December 2020

The paradox of beta-adrenergic blockade for the management of congestive heart failure

1 reference

12 December 2020

A cellular logic for G protein-coupled ion channel pathways

1 reference

12 December 2020

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

12 December 2020

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

12 December 2020

Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response

1 reference

12 December 2020

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

1 reference

12 December 2020

Chronic beta 1-adrenoceptor antagonist treatment sensitizes beta 2-adrenoceptors, but desensitizes M2-muscarinic receptors in the human right atrium

1 reference

12 December 2020

Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Bucindolol Investigators

1 reference

12 December 2020

Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart.

1 reference

12 December 2020

Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure

1 reference

12 December 2020

Ca2+ uptake by cardiac sarcoplasmic reticulum from patients with idiopathic dilated cardiomyopathy

1 reference

12 December 2020

Predictors of systolic and diastolic improvement in patients with dilated cardiomyopathy treated with metoprolol

1 reference

12 December 2020

ras p21 and GAP inhibit coupling of muscarinic receptors to atrial K+ channels

1 reference

12 December 2020

A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees

1 reference

12 December 2020

Pathophysiology of chronic heart failure

1 reference

12 December 2020

Improvement of cholera toxin-catalyzed ADP-ribosylation by endogenous ADP-ribosylation factor from bovine brain provides evidence for an unchanged amount of Gs alpha in failing human myocardium

1 reference

12 December 2020

Ca2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes

1 reference

12 December 2020

Stimulation of protein phosphatases as a mechanism of the muscarinic-receptor-mediated inhibition of cardiac L-type Ca2+ channels

1 reference

12 December 2020

Signal transduction by G proteins in cardiac tissues

1 reference

12 December 2020

Effect of captopril on myocardial beta-adrenoceptor density and Gi alpha-proteins in patients with mild to moderate heart failure due to dilated cardiomyopathy

1 reference

12 December 2020

Positive inotropic effect of carbachol and inositol phosphate levels in mammalian atria after pretreatment with pertussis toxin

1 reference

12 December 2020

Sodium fluoride attenuates the negative inotropic effects of muscarinic M2 and adenosine receptor agonists

1 reference

12 December 2020

Beneficial effects of metoprolol in heart failure associated with coronary artery disease: a randomized trial

1 reference

12 December 2020

M2-specific muscarinic cholinergic receptor-mediated inhibition of cardiac regulatory protein phosphorylation

1 reference

12 December 2020

In vivo beta-adrenergic stimulation leads to biphasic regulation of Gi alpha-2 gene transcriptional activity in rat heart

1 reference

12 December 2020

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group

1 reference

12 December 2020

Observations on the intracoronary administration of milrinone and dobutamine to patients with congestive heart failure

1 reference

12 December 2020

Isoprenaline-induced increase in mRNA levels of inhibitory G-protein ?-subunits in rat heart

1 reference

12 December 2020

Increase of Gi alpha in human hearts with dilated but not ischemic cardiomyopathy

1 reference

12 December 2020

Additive effects of dobutamine and amrinone on myocardial contractility and ventricular performance in patients with severe heart failure

1 reference

12 December 2020

Protein phosphatases: recent progress

1 reference

12 December 2020

New therapeutic strategies in chronic heart failure: challenge of long-term beta-blockade

1 reference

12 December 2020

Long term beta-adrenoceptor-mediated up-regulation of Gi alpha and G(o) alpha mRNA levels and pertussis toxin-sensitive guanine nucleotide-binding proteins in rat heart

1 reference

12 December 2020

Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure

1 reference

12 December 2020

Autonomic regulation of type 1 protein phosphatase in cardiac muscle.

1 reference

12 December 2020

Muscarinic cholinoceptors in the human heart: demonstration, subclassification, and distribution

1 reference

12 December 2020

Alterations in sarcoplasmic reticulum gene expression in human heart failure. A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium

1 reference

12 December 2020

Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure.

1 reference

12 December 2020

A placebo-controlled trial of captopril in refractory chronic congestive heart failure. Captopril Multicenter Research Group

1 reference

12 December 2020

Distinct down-regulation of cardiac beta 1- and beta 2-adrenoceptors in different human heart diseases

1 reference

12 December 2020

Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparations

1 reference

12 December 2020

Cell death in the failing heart: role of an unnatural growth response to overload.

1 reference

12 December 2020

Ionic Channels and Their Regulation by G Protein Subunits

1 reference

12 December 2020

Effects of adenosine receptor and muscarinic cholinergic receptor agonists on cardiac protein phosphorylation. Influence of pertussis toxin.

1 reference

12 December 2020

cAMP response element binding protein is expressed and phosphorylated in the human heart

1 reference

12 December 2020

Increased messenger RNA level of the inhibitory G protein alpha subunit Gi alpha-2 in human end-stage heart failure

1 reference

12 December 2020

Beta 1- and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure

1 reference

12 December 2020

cDNA cloning, functional expression, and mRNA tissue distribution of a third organellar Ca2+ pump

1 reference

12 December 2020

Isoprenaline-induced increase in the 40/41 kDa pertussis toxin substrates and functional consequences on contractile response in rat heart

1 reference

12 December 2020

Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation

1 reference

12 December 2020

Effects of bucindolol on neurohormonal activation in congestive heart failure

1 reference

12 December 2020

Differences in beta-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy

1 reference

12 December 2020

Lisinopril lowers cardiac adrenergic drive and increases beta-receptor density in the failing human heart

1 reference

12 December 2020

Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart

1 reference

12 December 2020

Isoprenaline stimulates gene transcription of the inhibitory G protein alpha-subunit Gi alpha-2 in rat heart.

1 reference

12 December 2020

G proteins and dual control of adenylate cyclase

1 reference

12 December 2020

Cardiac effects of adenosine and adenosine analogs in guinea-pig atrial and ventricular preparations: evidence against a role of cyclic AMP and cyclic GMP.

1 reference

12 December 2020

G proteins and the heart

1 reference

12 December 2020

Phosphodiesterase inhibition by enoximone in preparations from nonfailing and failing human hearts

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00227907

1 reference

26 September 2017

1 reference